Pentwater Capital Management’s Inspire Medical Systems INSP Stock Holding History

Pentwater Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$371K	–	145
2019 Q4	$371K	Sell	5,000 -7,500	-60%	-$482K	0.01%	132
2019 Q3	$763K	Sell	12,500 -17,500	-58%	-$1.15M	0.01%	117
2019 Q2	$1.82M	Sell	30,000 -5,000	-14%	-$269K	0.02%	117
2019 Q1	$1.99M	Sell	35,000 -15,000	-30%	-$810K	0.03%	89
2018 Q4	$2.11M	Buy	50,000 +45,000	+900%	+$1.91M	0.02%	85
2018 Q3	$210K	Sell	5,000 -2,680	-35%	-$126K	﹤0.01%	136
2018 Q2	$274K	Buy	+7,680	New	+$248K	﹤0.01%	116

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Pentwater Capital Management's INSP Position: Q1 2020 in Review

Pentwater Capital Management sold out of Inspire Medical Systems (INSP) in Q1 2020, closing a stake of 5,000 shares — an estimated $371K sold.

Pentwater Capital Management first reported a position in INSP in Q2 2018 and held it in 7 quarters. The position peaked at $2.11M in Q4 2018. 168 funds tracked by Wall St. Rank hold INSP as of Q1 2020.

Pentwater Capital Management reported no remaining Inspire Medical Systems position as of Q1 2020 after selling out during the quarter.
Pentwater Capital Management sold 5,000 Inspire Medical Systems shares in Q1 2020, an estimated $371K.
Pentwater Capital Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 7 quarters.
Pentwater Capital Management's Inspire Medical Systems position peaked at $2.11M in Q4 2018.
168 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.